DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Now, it’s worth noting Stock Advisor's total average return is 1,055% — a market-crushing outperformance compared to 194% for ...